Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the period. Barclays PLC’s holdings […]
Picton Mahoney Asset Management cut its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 49.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,830 shares of the biotechnology company’s stock after selling 1,776 shares during the quarter. Picton Mahoney Asset […]
Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the quarter. Barclays PLC owned 0.09% of […]
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023. Fourth Quarter FY2023...
Exscientia (NASDAQ:EXAI – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Risk & Volatility Exscientia has a beta of 0.47, indicating […]